|
|
|
|
| LEADER |
04162nmm a2200349 u 4500 |
| 001 |
EB000367040 |
| 003 |
EBX01000000000000000220092 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
130626 ||| eng |
| 020 |
|
|
|a 9781846281877
|
| 100 |
1 |
|
|a Valk, Peter E.
|e [editor]
|
| 245 |
0 |
0 |
|a Positron Emission Tomography
|h Elektronische Ressource
|b Clinical Practice
|c edited by Peter E. Valk, Dominique Delbeke, Dale L. Bailey, David W. Townsend, Michael N. Maisey
|
| 250 |
|
|
|a 1st ed. 2006
|
| 260 |
|
|
|a London
|b Springer London
|c 2006, 2006
|
| 300 |
|
|
|a XIV, 475 p
|b online resource
|
| 505 |
0 |
|
|a Basic Science of PET and PET/CT -- Incremental Value of Imaging Structure and Function -- The Technologist’s Perspective -- Radiation Protection and Dosimetry in PET and PET/CT -- Artifacts and Normal Variants in Whole-Body PET and PET/CT Imaging -- PET Imaging in Brain Tumors -- PET and PET/CT Imaging in Lung Cancer -- PET and PET/CT Imaging in Head and Neck Cancer -- PET and PET/CT Imaging in Lymphoma -- PET and PET/CT Imaging in Colorectal Cancer -- PET and PET/CT Imaging in Esophageal and Gastric Cancers -- PET and PET/CT Imaging in Tumors of the Pancreas and Liver -- PET and PET/CT Imaging in Breast Cancer -- PET and PET/CT Imaging in Testicular and Gynecologic Cancers -- PET and PET/CT Imaging in Melanoma -- PET and PET/CT Imaging in Urologic Tumors -- PET and PET/CT in Sarcoma -- PET and PET/CT Imaging in Thyroid and Adrenal Diseases -- PET and PET/CT Imaging in Multiple Myeloma, Solitary Plasmacytoma, MGUS, and Other Plasma Cell Dyscrasias -- Evolving Role of FDG-PET Imaging in the Management of Patients with Suspected Infection and Inflammatory Disorders -- PET Imaging of the Skeleton -- PET Imaging in Pediatric Disorders -- PET Imaging for Tumor Hypoxia: Characterizing the Tumor and Guiding Treatment -- Labeled Pyrimidines in PET Imaging -- Assessment of Treatment Response by FDG-PET -- PET in Clinical Cardiology -- Assessment of Coronary Artery Disease with Cardiac PET/CT -- PET in Clinical Neurology
|
| 653 |
|
|
|a Nuclear Medicine
|
| 653 |
|
|
|a Nuclear physics
|
| 653 |
|
|
|a Radiology
|
| 653 |
|
|
|a Nuclear and Particle Physics
|
| 653 |
|
|
|a Nuclear medicine
|
| 653 |
|
|
|a Oncology
|
| 700 |
1 |
|
|a Delbeke, Dominique
|e [editor]
|
| 700 |
1 |
|
|a Bailey, Dale L.
|e [editor]
|
| 700 |
1 |
|
|a Townsend, David W.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 028 |
5 |
0 |
|a 10.1007/1-84628-187-3
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/1-84628-187-3?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.0757
|
| 520 |
|
|
|a This text is based on the second half of P.E. Valk et al’s 2003 bestseller Positron Emission Tomography: Basic Science and Clinical Practice and deals with only the clinical research and applications. Positron Emission Tomography: Clinical Practice consists of twenty-two fully revised and thoroughly updated chapters enhanced further by six entirely new chapters. The abundance of new material makes this book an essential volume for anyone training in, or practicing, Nuclear Medicine. The first chapters of this book summarize the scientific aspects of PET and PET/CT including physics, instrumentation, radiation dosimetry and radiation protection. A chapter on normal variants in FDG PET imaging serves as an introduction to the clinical chapters. The clinical chapters cover a wide range of oncology applications and they have been updated to include the impact of FDG PET/CT imaging in oncology. Two chapters address imaging with tracers other than FDG, such as an hypoxic tracer. The book concludes with chapters on the use of PET and PET/CT in cardiology and neurology. A chapter on PET imaging of infectious processes is also included. The applications in this book will be useful for residents and those training in medical imaging specialties, as well as imaging professionals in private or academic practice who need to become familiar with this technology and its applications. This book will also be essential reading for those whose specialties carry over to PET and PET/CT, such as oncologists, cardiologists, neurologists and surgeons
|